1 Chapter Four Psychopharmacology .

32
1 Chapter Four Psychopharmacology http://upload.wikimedia.org/wikipedia/commons/6/64/Pyschoactive_Drugs.jpg

Transcript of 1 Chapter Four Psychopharmacology .

Page 1: 1 Chapter Four Psychopharmacology .

1

Chapter FourPsychopharmacology

http://upload.wikimedia.org/wikipedia/commons/6/64/Pyschoactive_Drugs.jpg

Page 2: 1 Chapter Four Psychopharmacology .

2

Psychopharmacology

the study of the effects of drugs on affect, cognition, and behavior

Ph

oto

dis

c/G

ett

y Im

ag

es

Page 3: 1 Chapter Four Psychopharmacology .

3

Types of Neurochemicals Neurotransmitters affect adjacent cells

across the synapse.

Neuromodulators diffuse away from the synapse to target cells some distance away.

Circulating neurohormones reach even more distant target cells.

Page 4: 1 Chapter Four Psychopharmacology .

4

Neurotransmitters

Page 5: 1 Chapter Four Psychopharmacology .

5

Acetylcholine (ACh)

Neuromuscular junction (movement)

Central nervous system (learning and memory)

Page 6: 1 Chapter Four Psychopharmacology .

6

Dopamine

Movement

Reinforcement

Planning

Page 7: 1 Chapter Four Psychopharmacology .

7

Serotonin

Mood

Appetite

Sleep

Page 8: 1 Chapter Four Psychopharmacology .

8

Glutamate The major excitatory neurotransmitter of

the central nervous system.

Extended presence may be toxic

Page 9: 1 Chapter Four Psychopharmacology .

9

GABA

GABA is the major inhibitory neurotransmitter of the central nervous system.

The GABAA receptor interacts with a number of drugs.

Page 10: 1 Chapter Four Psychopharmacology .

10

Why is Inhibition Important?

Tetanospasmin (tetanus toxin) hitches a ride to the central nervous system from a wound site using the retrograde transport system within axons.

The toxin binds to receptor sites for gamma-aminobutyric acid (GABA), and can’t be dislodged.

Without normal inhibitory input from GABA, muscles begin to go into sudden, involuntary contractions, or spasms.

Page 11: 1 Chapter Four Psychopharmacology .

11

Drug Actions at the Synapse Agonists boost the activity of a

neurotransmitter.

Antagonists interfere with the action of a neurotransmitter.

Page 12: 1 Chapter Four Psychopharmacology .

12

Lifespan of a neurotransmitter1. Synthesis

2. Storage

3. Release

4. Action on the target cell

5. Deactivation

Page 13: 1 Chapter Four Psychopharmacology .

13

Deactivation of Neurotransmitters

Page 14: 1 Chapter Four Psychopharmacology .

14

Drugs and Serotonin

Page 15: 1 Chapter Four Psychopharmacology .

15

Drugs and Acetylcholine

Page 16: 1 Chapter Four Psychopharmacology .

16

Agonists and Antagonists

Copyright © Houghton Mifflin Company. All rights reserved.

Go to Slide Show View (press F5) to play the video or animation. (To exit, press Esc.)

This media requires PowerPoint® 2000 (or newer) and the Macromedia Flash Player (7 or higher).[To delete this message, click inside the box, click the border of the box, and then press delete.]

Click in this box to enter notes.

Page 17: 1 Chapter Four Psychopharmacology .

17

Basic Principles of Drug Effects Placebo effects

Individual differences Gender Size Genetics

Page 18: 1 Chapter Four Psychopharmacology .

Allyn & Bacon 2004

Principles of PharmacologyRoutes of Administration

Intravenous (IV) injection: Injection of a substance directly into a vein.

Intraperitoneal (IP) injection: The Injection of a substance into the peritoneal cavity-

the space that surrounds the stomach, intestines, liver, and other abdominal organs.

Inhalation: Administration of a vaporous substance into the lungs.

Page 19: 1 Chapter Four Psychopharmacology .

Allyn & Bacon 2004

Principles of PharmacologyRoutes of Administration

Intramuscular (IM) injection: Injection of a substance into a muscle.

Subcutaneous (SC) injection: Injection of a substance into the space beneath the

skin.

Oral administration: Administration of a substance into the mouth, so it is

swallowed.

Page 20: 1 Chapter Four Psychopharmacology .

20

Method of Administration Affects Blood Concentration

Basic Principles of Drug Effects

Page 21: 1 Chapter Four Psychopharmacology .

21

Tolerance the need to administer more of a drug to produce the

same effects may occur due to:

changes in enzymes changes at the level of the synapse learning

Withdrawal occurs when some drugs are discontinued, leads to behavioral effects that are typically the opposite

of the effects produced by the drug

Basic Principles of Drug Effects

Page 22: 1 Chapter Four Psychopharmacology .

22

Tolerance and Withdrawal

Page 23: 1 Chapter Four Psychopharmacology .

23

Addiction

a compulsive need to readminister a drug. The dopamine reward system, including the

nucleus accumbens, has been implicated in addiction.

Addiction is the result of complex physical and environmental variables, making it extremely challenging to treat.

Page 24: 1 Chapter Four Psychopharmacology .

24

Pleasure and Reward Olds and Milner (1954) reported that rats

would work for electrical self-stimulation of the brain (ESB).

Page 25: 1 Chapter Four Psychopharmacology .

25

ESB and the Mesolimbic System

ESB is very strong in the medial forebrain bundle (MFB).

MFB makes connections between the midbrain and the limbic system.

Many neurons in this system use dopamine.

This system may function as a “reward circuit.”

Page 26: 1 Chapter Four Psychopharmacology .

26

ESB, Dopamine and the Nucleus Accumbens ESB in the ventral tegmentum is associated with

increased release of dopamine in the nucleus accumbens.

These circuits may underlie natural reward and addictive behaviors.

Page 27: 1 Chapter Four Psychopharmacology .

27

Pleasure and Reward Heath (1963) investigated ESB in human

participants.

Page 28: 1 Chapter Four Psychopharmacology .

28

Stimulants Stimulant drugs increase alertness and

mobility. This class includes:

Nicotine Cocaine Amphetamine Ecstasy (MDMA) Caffeine

© CORBIS

Page 29: 1 Chapter Four Psychopharmacology .

29

Caffeine in Common Products

Page 30: 1 Chapter Four Psychopharmacology .

30

Cocaine Dopamine reuptake inhibitor Effects:

Alertness, elevated mood, confidence, well-being High doses – symptoms similar to schizophrenia

(hallucinations, paranoid delusions, repetitive movements) ©

Mich

ae

l S. Y

am

ash

ita/C

OR

BIS

Page 31: 1 Chapter Four Psychopharmacology .

31

MDMA (Ecstasy) MDMA increases the release of serotonin, which has

a toxic effect on serotonergic neurons.

After MDMA administration

Courtesy Una D. McCann, Johns Hopkins Medical Institute

Normal brain tissue

http://www.creativewell.com/smith.html

Page 32: 1 Chapter Four Psychopharmacology .

32

Other drug types Alcohol

Opiates

Hallucinogens